Literature DB >> 23312596

Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.

Christopher J Obara1, Kimberly A Dowd, Julie E Ledgerwood, Theodore C Pierson.   

Abstract

Neutralization of flaviviruses requires engagement of the virion by antibodies with a stoichiometry that exceeds a required threshold. Factors that modulate the number of antibodies bound to an individual virion when it contacts target cells impact neutralization potency. However, the contribution of cellular factors to the potency of neutralizing antibodies has not been explored systematically. Here we investigate the relationship between expression level of a viral attachment factor on cells and the neutralizing potency of antibodies. Analysis of the attachment factor DC-SIGNR on cells in neutralization studies failed to identify a correlation between DC-SIGNR expression and antibody-mediated protection. Furthermore, neutralization potency was equivalent on a novel Jurkat cell line induced to express DC-SIGNR at varying levels. Finally, blocking virus-attachment factor interactions had no impact on neutralization activity. Altogether, our studies suggest that cellular attachment factor expression is not a significant contributor to the potency of neutralizing antibodies to flaviviruses.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312596      PMCID: PMC3601793          DOI: 10.1016/j.virol.2012.11.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  60 in total

Review 1.  Neutralization and antibody-dependent enhancement of dengue viruses.

Authors:  Scott B Halstead
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

2.  Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies.

Authors:  J W Yewdell; A J Caton; W Gerhard
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  Proteolytic activation of tick-borne encephalitis virus by furin.

Authors:  K Stadler; S L Allison; J Schalich; F X Heinz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  A hypothesis accounting for the effect of the host cell on neutralization-resistant virus.

Authors:  L Kjellén
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

Review 5.  A multi-hit model for the neutralization of animal viruses.

Authors:  A J Della-Porta; E G Westaway
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

6.  Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.

Authors:  L J Grady; W Kinch
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

7.  Mechanisms of neutralization of influenza virus in tracheal epithelial and BHK cells vary according to IgG concentration.

Authors:  M C Outlaw; S J Armstrong; N J Dimmock
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

8.  Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  I Kurane; D Hebblewaite; W E Brandt; F A Ennis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010.

Authors:  L R Petersen; P J Carson; B J Biggerstaff; B Custer; S M Borchardt; M P Busch
Journal:  Epidemiol Infect       Date:  2012-05-28       Impact factor: 4.434

Review 10.  Manipulation of cell surface macromolecules by flaviviruses.

Authors:  Robert Anderson
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

View more
  1 in total

1.  The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

Authors:  Laura A VanBlargan; Swati Mukherjee; Kimberly A Dowd; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.